MedTrace Logo

The Analgesic Effects of Melatonin

NCT01923974 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-10-22

No results posted yet for this study

Summary

A study investigating the analgesic effect of melatonin in a human heat injury model using quantitative sensory testing.

Conditions

  • Analgesia
  • Antihyperalgesia

Interventions

DRUG

Melatonin 10 mg

DRUG

Melatonin 100 mg

DRUG

Placebo

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER

  • Lars Peter Holst Andersen

    lead OTHER

Principal Investigators

  • Lars P.H. Andersen, MD · Herlev Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-06-30
Completion
2014-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01923974 on ClinicalTrials.gov